How will the Medicare Part D benefit change under current law and leading proposals?

How will the Medicare Part D benefit change under current law and leading proposals?

Collection:
Health Policy and Services Research
Series Title(s):
Issue brief (Henry J. Kaiser Family Foundation)
Author(s):
Cubanski, Juliette, author
Neuman, Tricia, author
Contributor(s):
Henry J. Kaiser Family Foundation, issuing body.
Publication:
San Francisco, CA : Henry J. Kaiser Family Foundation, October 2019
Language(s):
English
Format:
Text
Subject(s):
Medicare Part D -- economics
Drug Costs
United States
Genre(s):
Technical Report
Abstract:
Since 2006, Medicare beneficiaries have had access to prescription drug coverage through Part D, where private plan sponsors contract with Medicare to provide the drug benefit. In recent years, policymakers have expressed concerns about the absence of a hard cap on out-of-pocket spending for Part D enrollees, the significant increase in Medicare spending for enrollees with high drug costs, and the relatively weak financial incentives faced by Part D plan sponsors to control high drug costs. Recent proposals aim to address these concerns, including the Trump Administration's Fiscal Year 2020 budget, the bipartisan prescription drug bill passed by the Senate Finance Committee, and H.R.3, the prescription drug bill recently announced by Speaker Pelosi (D-CA). This brief describes how the Medicare Part D benefit will change in 2020 under current law and proposed changes that would affect what beneficiaries, plans, manufacturers, and Medicare pay for drug costs under Part D in the future.
Copyright:
Reproduced with permission of the copyright holder. Further use of the material is subject to CC BY license. (More information)
Extent:
1 online resource (1 PDF file (6 pages))
Illustrations:
Illustrations
NLM Unique ID:
101767693 (See catalog record)
Permanent Link:
http://resource.nlm.nih.gov/101767693